Ilika Makes Commercial Progress in Stereax and Goliath Solid-State Battery Businesses
Ilika PLC has made notable commercial advancements across its Stereax and Goliath solid-state battery businesses. The company is now supplying commercial-grade electrodes to Cirtec for use in the M300 medical device, expected to launch later this year. Ilika recognized approximately £100,000 in revenue from Stereax during the previous financial year and anticipates growth as well as royalty income once products reach end customers. The Goliath program has also reached a key milestone with 10Ah prototypes shipped for validation by OEMs and commercial clients. These cells have attracted interest beyond electric vehicles, particularly in defense and e-bike markets. Ilika plans to expand into these sectors using funds from its recent £5 million fundraising. Looking ahead, investors are advised to monitor milestones such as royalty payments under Stereax and the delivery of 10Ah commercial products for Goliath.
Topics: commercial production medical devices revenue generation solid-state batteries